Regulations.gov document
Reference 3 - Woodcock J. (Acting Commissioner, U.S. Food and Drug Administration, Silver…
Supporting & Related Material · FDA-2022-P-2425 · posted Apr 25, 2024
Key facts
| Document ID | FDA-2022-P-2425-0006 |
|---|---|
| Title | Reference 3 - Woodcock J. (Acting Commissioner, U.S. Food and Drug Administration, Silver Spring, MD). Letter to: Phipps M. (Chief Executive Officer, American College of Obstetricians and Gynecologists, Washington, D.C.). Grobman W. (President, Society for Maternal-Fetal Medicine, Washington, D.C.). 2021 April 12. Available from: https://www.aclu.org/letter/fda-response-acog-april-2021 |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2022-P-2425 |
| Posted | Apr 25, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: